Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 19, 2022

BUY
$225.82 - $368.51 $1.96 Million - $3.19 Million
8,666 Added 304.5%
11,512 $2.55 Million
Q2 2021

Jul 29, 2021

BUY
$129.91 - $234.98 $519 - $939
4 Added 0.14%
2,846 $669,000
Q1 2021

Apr 13, 2021

SELL
$109.18 - $185.98 $1,637 - $2,789
-15 Reduced 0.53%
2,842 $372,000
Q4 2020

Jan 19, 2021

BUY
$65.74 - $169.86 $93,876 - $242,560
1,428 Added 99.93%
2,857 $298,000
Q4 2020

Jan 13, 2021

SELL
$65.74 - $169.86 $169,017 - $436,710
-2,571 Reduced 64.28%
1,429 $298,000
Q3 2020

Oct 09, 2020

BUY
$54.34 - $94.85 $217,360 - $379,400
4,000 New
4,000 $283,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Intelligence Driven Advisers, LLC Portfolio

Follow Intelligence Driven Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Intelligence Driven Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Intelligence Driven Advisers, LLC with notifications on news.